WO2005037294A8 - Compositions for controlling parasites comprising a combination of abamectin and ivermectin - Google Patents

Compositions for controlling parasites comprising a combination of abamectin and ivermectin

Info

Publication number
WO2005037294A8
WO2005037294A8 PCT/EP2004/052554 EP2004052554W WO2005037294A8 WO 2005037294 A8 WO2005037294 A8 WO 2005037294A8 EP 2004052554 W EP2004052554 W EP 2004052554W WO 2005037294 A8 WO2005037294 A8 WO 2005037294A8
Authority
WO
WIPO (PCT)
Prior art keywords
ivermectin
abamectin
combination
compositions
controlling parasites
Prior art date
Application number
PCT/EP2004/052554
Other languages
French (fr)
Other versions
WO2005037294A1 (en
Inventor
Sun Cho Hyun
Santos Junior Edival
Costa Alvimar Jose Da
Original Assignee
Akzo Nobel Nv
Sun Cho Hyun
Santos Junior Edival
Costa Alvimar Jose Da
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv, Sun Cho Hyun, Santos Junior Edival, Costa Alvimar Jose Da filed Critical Akzo Nobel Nv
Priority to NZ546340A priority Critical patent/NZ546340A/en
Priority to AU2004281551A priority patent/AU2004281551B2/en
Priority to CN2004800305841A priority patent/CN1867341B/en
Priority to BRPI0415366-9A priority patent/BRPI0415366A/en
Publication of WO2005037294A1 publication Critical patent/WO2005037294A1/en
Publication of WO2005037294A8 publication Critical patent/WO2005037294A8/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

A long acting composition for controlling parasites in and on animals, which comprises in a slow release vehicle a combination of ivermectin and abamectin, wherein the total percentage w/v of ivermectin and abamectin equals or exceeds 3% w/v and the concentration of ivermectin is higher than the concentration of abamectin.
PCT/EP2004/052554 2003-10-17 2004-10-15 Compositions for controlling parasites comprising a combination of abamectin and ivermectin WO2005037294A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NZ546340A NZ546340A (en) 2003-10-17 2004-10-15 Compositions for controlling parasites comprising a combination of abamectin and ivermectin
AU2004281551A AU2004281551B2 (en) 2003-10-17 2004-10-15 Compositions for controlling parasites comprising a combination of abamectin and ivermectin
CN2004800305841A CN1867341B (en) 2003-10-17 2004-10-15 Compositions for controlling parasites comprising a combination of abamectin and milbemycin
BRPI0415366-9A BRPI0415366A (en) 2003-10-17 2004-10-15 long-acting composition to control parasites internal and external to animals, and use of the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03078280 2003-10-17
EP03078280.9 2003-10-17

Publications (2)

Publication Number Publication Date
WO2005037294A1 WO2005037294A1 (en) 2005-04-28
WO2005037294A8 true WO2005037294A8 (en) 2005-07-21

Family

ID=34442985

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2004/052554 WO2005037294A1 (en) 2003-10-17 2004-10-15 Compositions for controlling parasites comprising a combination of abamectin and ivermectin

Country Status (7)

Country Link
CN (1) CN1867341B (en)
AU (1) AU2004281551B2 (en)
BR (1) BRPI0415366A (en)
NZ (1) NZ546340A (en)
TR (1) TR200601608T1 (en)
WO (1) WO2005037294A1 (en)
ZA (1) ZA200603931B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849363A1 (en) * 2006-03-09 2007-10-31 Cheminova A/S Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin
WO2010008891A2 (en) * 2008-06-24 2010-01-21 Merial Limited Anthelminthic formulations
CN104168886A (en) 2012-03-13 2014-11-26 拜耳新西兰有限公司 Long acting compositions
CN104430394A (en) * 2014-10-20 2015-03-25 广西大学 Preparation method of ivermectin/emamectin benzoate compound microcapsule suspension
CN109329077A (en) * 2018-09-27 2019-02-15 江苏省协同医药生物工程有限责任公司 A kind of anti parasitic experimental animal padding and preparation method thereof
CN110721152B (en) * 2018-12-29 2022-01-14 瑞普(天津)生物药业有限公司 Sustained-release composition for treating animal skin parasite and fungus infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
CN1375293A (en) * 2001-03-16 2002-10-23 王玉万 Mixed vermifuge injection containing iodo-ether salicylamine
BR0104761A (en) * 2001-08-08 2003-08-12 Inst De Pesquisa Em Saude Anim Abamectin plus ivermectin combination for use as endectocide in cattle

Also Published As

Publication number Publication date
AU2004281551B2 (en) 2009-10-29
ZA200603931B (en) 2007-09-26
CN1867341B (en) 2010-06-16
NZ546340A (en) 2009-08-28
WO2005037294A1 (en) 2005-04-28
BRPI0415366A (en) 2006-12-12
TR200601608T1 (en) 2006-12-21
CN1867341A (en) 2006-11-22
AU2004281551A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
WO2001051456A3 (en) Antibacterial agents
WO2007044032A3 (en) Compositions having a high antiviral and antibacterial efficacy
EP2338332A3 (en) Hollow glucan particle or cell wall particle encapsulating a terpene component
AU2001264303A1 (en) Compositions controlling release ph range and/or speed
WO2007075747A3 (en) Uv-radiation protectant compositions
AU2003266870A1 (en) Composition for combating/repelling insects, birds, dirts and parasites
AU2003303598A1 (en) Compositions, methods, and systems for inferring bovine breed
AU2719300A (en) Antimicrobial compositions containing photosensitizers, articles, and methods ofuse
WO2008098168A3 (en) High-dose, long-acting ectoparasiticide for extended control
WO2006062847A3 (en) Compositions having a high antiviral and antibacterial efficacy
CA2387198A1 (en) Method for treating hair loss using thyromimetic compounds
WO2004032872A3 (en) Epo D + 5-FU/GEMCITABINE
AU2002952136A0 (en) "Modified Polymeric Compositions"
WO2004092173A3 (en) A2a adenosine receptor antagonists
AU2003297318A1 (en) Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476.
EP1319402A4 (en) Ige production inhibitors
EP1192938A3 (en) Composition to enhance permeation of topical skin agents
AU2002357674A1 (en) Luminescing and/or fluorescing radiation-curable, cyanoacrylate-containing compositions
CA2316112A1 (en) Release agents for bituminous substances
WO2002092024A3 (en) Compounds and methods for inhibiting axillary malodour
WO2005037294A8 (en) Compositions for controlling parasites comprising a combination of abamectin and ivermectin
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
HUP0303265A3 (en) Avermectins substituted in the 4"-position having pesticidal properties, compositions containing them and use thereof
WO2004034961A3 (en) Antimicrobial agents and uses thereof
AU2002345878A1 (en) Ilt3 and ilt4-related compositions and methods

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480030584.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWE Wipo information: entry into national phase

Ref document number: 546340

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2006/01608

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2006/004053

Country of ref document: MX

Ref document number: 2004281551

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 1314/CHENP/2006

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 06036664

Country of ref document: CO

ENP Entry into the national phase in:

Ref document number: 2004281551

Country of ref document: AU

Date of ref document: 20041015

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 2004281551

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2006/03931

Country of ref document: ZA

Ref document number: 200603931

Country of ref document: ZA

122 Ep: pct application non-entry in european phase
ENP Entry into the national phase in:

Ref document number: PI0415366

Country of ref document: BR